Ethacrynate Sodium Injection, Powder, For Solution
Product Images NDC 42023-157

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ethacrynate Sodium (NDC 42023-157). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 1)

Chemical structure diagram of ethacrynate sodium, showing a benzene ring with chlorine atoms, carboxyl group, and other side chains representing the active ingredient's molecular structure.*

FDA Label Image

Chemical Structure (Image 2)

Chemical structure of ethacrynate sodium. The diagram shows the molecular structure with specific chemical groups and bonds, including two chlorine atoms, a sodium carboxylate group, and a distinct side chain with ketone and alkene functionalities.*

FDA Label Image

Carton 3003371a (Image 3)

Box packaging label for Ethacrynate Sodium For Injection, USP 50 mg/vial by Par Pharmaceutical, Inc. The label indicates a single dose vial containing 50 mg of ethacrynate acid equivalent. The label includes storage instructions, usual adult dosage guidance, and notes that the vial stopper is not made with natural rubber latex. The NDC is 42023-157-01 and the product is for intravenous use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.